Abstracts

  • The ECU ISCP 2026 offers an opportunity for Researchers, graduates and undergraduate students to showcase their studies.

Abstract Submission Guidelines:

      1. Announcement for Acceptance for early submission:18/12/2025
      2. Announcement for Acceptance for regular submission: 24/12/2025
      3. The corresponding author will receive an email with a link to pay the registration fees after the abstract is accepted.
      4. The participants shall send the scanned payment proof by email to pharma.conference@ecu.edu.eg
      5. Payment must be done within maximum 5 days of abstract acceptance or delegate registration; otherwise, registration will be cancelled.
      6. Accepted abstracts will be published in the special issue of Transitional Health Sciences Journal (THS) on the Egyptian Knowledge Bank platform.

Please check the following items carefully before submitting your abstract.

  1. language: English
  2. Title:
    • Ensure that your title is clear, concise and indicates what the research is about.
    • Maximum length: 90 characters including spaces.
    • Font: Times New Roman and in Bold
    • Font size:  14 pt.
    • Line spacing: 1.15

 3. Author(s) Names

    • Include full first name, middle name, surname (in this order). Names should appear below the title.
    • Authors’ affiliations should be added below the author list, using superscript numbers to specify which authors are linked to each organization. Affiliation in this context is an author’s academic institution, company or place of work which is affiliated with this study.
    • The authors’ affiliations should be listed below their names in Times New Roman, Italic, font size 11, and line spacing 1.15.

 4. Abstract Body

  • The main body of your abstract should not exceed 300 words (Click here to see how to count words). The word limit does not include your abstract title, author list, figure legends, sub-headings, or references.
  •  The abstract should follow a basic structure as outlined below:                                                                                                                         A. It should be written in: Times New Roman, Font size 12, Regular, Line spacing 1.5.                                                                                   B. It should be submitted as a single paragraph including: introduction, aim, methods, results, discussion, and conclusions (including study limitations).    

 5. Keywords                                                                                                                                                                                                                                        

 About 3-7 key words (must be arranged alphabetically), must be included below the abstract body.

 Key words should be written in: Times New Roman, Font size 12, Italic, and Line spacing 1.5.

Tracks of the abstracts of the postgraduates, staff and undergraduates include, but is not limited to;

 Integration of Western & Chinese Medicine

 Safety, quality control, and dosage standardization of herbal products

 Pharmacognosy research on medicinal plants

 AI Applications in Pharmacy

 AI-based drug discovery and development, and formulation

 Machine learning in disease prediction or treatment optimization

 Pharmaceutical Technology & Innovative Dosage Forms

 Nanotechnology for natural or synthetic drugs

 Novel drug delivery systems inspired by natural products

 Quality-by-Design (QbD) approaches using AI tools

 Clinical Pharmacy & Therapeutics

 Case studies integrating herbal and conventional therapies

 Evidence-based treatment guidelines combining TCM & Western medicine

 Analytical Chemistry & Quality Control

 Chemometric or AI-assisted analysis of herbal medicines

 Analytical evaluation of natural products

 Public Health, Community Pharmacy & Health Informatics

 Digital health tools for improving pharmacy services

 Public health applications of TCM

 Biomarkers for Integrated Therapy

 Present biochemical biomarkers used to evaluate combined therapies:

 Inflammatory markers (CRP, IL-6, TNF-α)

 Oxidative stress markers (GSH, MDA)

 Metabolic markers (HbA1c, lipid profiles)

AI-assisted identification of novel biomarkers for personalized integrative treatment.

 

Scroll to Top